2001 – 2006 – Member of the National Institute of Health Grant Review Study Section – Brain Disorders and Clinical Neuroscience 1 (BDCN-1/CND)
October 2003 – Invited Participant -NIH-NINDS – Priorities for Clinical Research in the Treatment of Acute, non-Traumatic Intracerebral Hemorrhage Workshop, 2003. The panel was established to create new guidelines for research in ICH treatment
November 2003 – Invited speaker, NIH-NINDS Stroke Conference
2004 – 2009 – Brain 2 – American Heart Association- grant review panel (co-chairman of the study group)
November 2005 – NINDS Special Emphasis Panel ZNS1 SRB-M Study Section
2005 – Advisory Board member for the 1st International Symposium on Cerebral Hemorrhage. Ann Arbor, Michigan
November 2006 – Planning Committee member – NIH, NINDS Workshop on Models of Geriatric Epilepsy
April 2006 – Loan Repayment Program NIH Study Sections – 2006/08 ZNS1 SRB-M (35)
March 2008 – NIH/NINDS – Special Emphasis Panel/Scientific Review 2008/05 ZNS1 SRB-M (57)
September 2008 NIH 10 ZRG1 BDCN-N (93) S Neurodegenerative Disorders and Injury
October 2008 – present, NIH, NINDS, Charter Member – Neurological Sciences Training Initial Review Group, NST-2 (F30 and K99 awards)
June 2009 – NIH – RFA-OD-09-003 Challenge Grant Panel 11
October 2009 – NIH – Acute Neural Injury and Epilepsy Study Section (ANIE) Brain Disorders and Clinical Neuroscience Integrated Review Group
February 2010 – Invited Moderator of a session on “Hemorrhage – Intraparenchymal” – International Stroke Conference, San Antonio, Texas
March 2010 – Invited Chairman of the session on Hematoma Resolution – International Intracerebral Hemorrhage Conference, Palm Springs, CA
April 2010 – Invited Speaker at 27th Princeton Conferences on Cerebrovascular Disease, Boston, MA
July 2010 – Invited lectures at the symposium “Nuclear receptors”; WorldPharma2010, Copenhagen, Denmark
March 2011 – Invited lectures at the 2ndVenusberg Meeting on Neuroinflammation. Bonn. Germany.
June 2011 – NIH – Acute Neural Injury and Epilepsy Study Section (ANIE) Brain Disorders and Clinical Neuroscience Integrated Review Group
2011 – NIH, NINDS. Stroke Progress Review Group (SPRG) – Topic – Intracerebral Hemorrhage advisory panel –The panel was established to create new research and clinical recommendations to NIH. Co-Chairman of the panel.
2011 – 2015, Board of Directors of the International Society for Cerebral Blood Flow and Metabolism (ISCBFM).
August 2012 – Member of Planning Group to Establish NIH Future Goals/Priorities in Stroke Research – NIH, NINDS. Stroke Progress Review Group (SPRG), Bethesda.
September 2012, NIH. ZRG1 BDCN-W 02, Brain Disorders and Clinical Neuroscience Integrated Review Group
August 2012 – Gordon Research Conference — Brain Energy Metabolism and Blood Flow – Chairman of the “Neuroinflammation” session
November, 2012 – NIH-NINDS Neurological Sciences and Disorders K (NSD-K) review panel and ZNS1 SRB-G (62) PHASE III CLINICAL TRIALS
April 2013 – NIH- Special Emphasis Panel/Scientific Review Group 2013/05 ZNS1 SRB-G (65)
June 2013. NIH – ZRG1 BDCN-N (55) RPAR Panel: Brain Disorders in the Developing World Research Across the Lifespan
November 2013. NIH-NINDS Neurological Sciences and Disorders K (NSD-K) review panel. PHASE III CLINICAL TRIALS